A loan of $765m agreed by the US International Development Finance Corporation to allow Kodak to establish a domestic pharmaceuticals unit has been put on hold until allegations of wrongdoing are resolved, amid reports of a US Securities and Exchange Commission investigation over the deal and rumors about insider trading.
In late July, the DFC agreed to grant a $765m loan to support the launch of Kodak Pharmaceuticals to manufacture...





